The term urotensin generally refers to injectable urotensin, which is mostly injected in the gluteal or upper arm deltoid area. Injectable urotensin is a gonadotropin drug, which has the effect of promoting the development and maturation of follicles in the ovaries, the production of testes and the secretion of steroidal sex hormones. It is used in combination with chorionic gonadotropin for the treatment of primary or secondary amenorrhea caused by insufficient gonadotropin secretion and infertility caused by anovulation. The injection site is usually in the gluteal area or the deltoid muscle of the upper arm. Injections are contraindicated for drug allergy and for those suffering from premature ovarian failure, uterine fibroids, ovarian cysts, and injectable urogonadotropins are also contraindicated for some women with unexplained vaginal bleeding and menopause. Usually asthma, epilepsy, renal insufficiency and athletes use this drug with caution to prevent accidents. If severe ovarian hyperstimulation syndrome occurs during the use of the drug, it should be discontinued immediately. It is recommended to use Uroseptin for Injection under the supervision of a physician, and not to use the drug on your own or adjust the dosage of the drug arbitrarily.